Rare diseases
Investigational molecules
Locations
Back to Germany262 clinical trials in Bochum, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
GermanyStudy on Lasmiditan for Treating Migraine in Children Aged 6 to 17
GermanyStudy on Insulin Lispro and Insulin Human for Managing Blood Sugar After Meals in Type 1 Diabetes Patients with Different Gastric Emptying Rates
GermanyStudy on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal
GermanyStudy on B-Cell Levels in Infants Exposed to Ocrelizumab During Pregnancy for Mothers with Multiple Sclerosis or Clinically Isolated Syndrome
GermanyStudy of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
GermanyStudy on the Safety and Effects of PTC518 for Patients with Huntington's Disease
GermanyStudy on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients
GermanyStudy on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GermanyStudy on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease
GermanyStudy Comparing Inclisiran and Bempedoic Acid for Lowering LDL Cholesterol in Patients with Atherosclerotic Cardiovascular Disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on skin conditions, including studies for cutaneous lupus erythematosus, hidradenitis suppurativa, and plaque psoriasis. Novel therapeutic approaches are being evaluated to improve treatment outcomes for patients with chronic skin disorders.
Multiple studies are investigating new medications for moderate to severe cases of these conditions.
Innovative research in cancer treatment, particularly focusing on colorectal cancer, pancreatic cancer, gastric cancer, and non-small cell lung cancer. These trials are evaluating targeted therapies and combination treatments.
New therapeutic approaches combining immunotherapy with targeted treatments are being studied.
Studies focusing on heart failure prevention and chronic kidney disease management. Research includes innovative combination therapies and preventive approaches for high-risk patients.
Trials are evaluating new treatment combinations to improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
